DOCSLIB.ORG

Diagnostic Role of Bone Marrow Examination in Detecting Haematological and Nonhaematological Disorders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnostic Role of Bone Marrow Examination in Detecting Haematological and Nonhaematological Disorders DOI: https://doi.org/10.3329/medtoday.v31i1.40315 ORIGINAL ARTICLE OPEN ACCSESS Diagnostic Role of Bone Marrow Examination in Detecting Haematological and Nonhaematological Disorders Md. Rezaul Karim Chowdhury *1, Md. Haroon ur Rashid 2, Amina Begum 3 Abstract Introduction: Bone marrow study has wide application in clinical medicine. It is important test not only for diagnosis of haematological diseases but also for various systemic illnesses. The aim of this study is to determine the indications, the spectrum of haemotological and non haematological disorders diagnosed by using this procedure. Materials & Methods: It was a prospective study comprising 152 patients who underwent bone marrow examination for evaluation of haematological and nonhaematological disorders in the Department of Haematology, Enam Medical College Hospital during the period of 2012 to 2017. Results: In our study male to female ratio was 1.6:1 and common age group was >45years (n-65, 42.76%). Most common indications for bone marrow examination were pancytopenia (26.97%, n-41) and diagnosis of leukaemia/myeloproliferative neoplasm (25.66%, n-38). 90.13% (n-137) marrows were pathological. Non-malignant conditions were 40.79% (n-62) and malignant conditions were 49.43% (n-75). Non malignant haematological condition were 33.55% (n-51), malignant haematological conditions were 47.37% (n-72). Most common nonmalignant haematological conditions were aplastic anaemia (15.13%, n-23) and immune thrombocytopenic purpura (9.87%, n-15). Visceral leishmaniasis was found 3.29% (n-5). Acute myelogenous leukaemia (14.47%, n-22) and multiple myloma (11.18%, n-17) were the most common malignant haematological condition. Secondary deposit was found 1.97% (n-3). Conclusion: Bone marrow examination is a simple invasive procedure for diagnosis of both haematological and nonhaematological diseases when routine investigations failed to reach the final diagnosis. Keywords: Bone marrow examination, Haematological disease, Nonhaematological disease. Number of Tables: 03; Number of References: 21; Number of Correspondesces: 03 Introduction *1. Corresponding Author: Bone marrow is an extremely cellular connective tissue that Dr. Md. Rezaul Karim Chowdhury fills the medullary cavities of bone. It is composed of haemopoietic cells, marrow adipose tissue and supportive MBBS, MD, D-Card stromal cells. On gross inspection, it may have a red or Associate Professor yellow color. Red marrow is actively engaged in the Department of Haematology production of blood cells and represents the active or haemopoietic marrow. Yellow (fatty) marrow is inactive, and Enam Medical College & Hospital, Savar. its principal cellular components are fat cells. Progressive Email: [email protected] differentiation and maturation of the primitive stem cells results in specific marrow cell type i.e. Leucocytes, Mobile: 01712141988 Erythrocytes and Platelets1. Haematological and 2. Dr. Md. Haroon ur Rashid nonhaematological diseases affecting the bone marrow may MBBS, MD be primarily or a secondarily spread to the marrow. In both cases the normal marrow cellular architecture is damaged or Associate Professor displaced. The pattern of disorders affecting the marrow is Department of Pulmonology quite different in developing countries than from developed 2, 3 Enam Medical College & Hospital, Savar. countries . In most of the cases, diagnosis can be arrived at by a detailed history, physical examination and few simple 3. Dr. Amina Begum investigations. But in certain cases bone marrow MBBS, MD examination is required for the confirmation of diagnosis. Medical Officer Bone marrow aspiration and trephine biopsy are important test not only for haematological diagnosis but also for Department of Physiology various systemic illnesses including pyrexia of unknown Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. origin, granulomatous diseases, storage disorders, haemophagocytic syndrome, histiocytosis, leishmaniasis and even resistant cases of malaria can be diagnosed through 2019 Volume 31 Number 01 15 Received: 26 July 2018 Accepted revised version: 09 September 2018 Diagnostic Role of Bone Marrow Examination Chowdhury, et al. marrow examination 4. These are simple relatively safe (n-75). Non malignant haematological condition were invasive procedure carried out routinely in hospital even in 33.55% (n-51), malignant haematological conditions were presence of severe thrombocytopenia. 47.37% (n-72). This study was carried out with the aim to explore the role Most common nonmalignant haematological conditions of this invasive procedure in ascertaining the diagnosis of were aplastic anaemia (15.13%, n-23) and immune haematological and non haematological diseases in our thrombocytopenic purpura (9.87%, n-15). Visceral clinical setup. leishmaniasis was found 3.29% (n-5). Materials and Methods Acute myelogenous leukaemia (14.47%, n-22) and Abstract multiple myloma (11.18%, n-17) were the most common This prospective study was done in the department of malignant conditions. Secondary deposit was found 1.97% Introduction: Bone marrow study has wide application in clinical medicine. It is important test not only for diagnosis of haematology, Enam Medical College Hospital (EMCH) (n-3). Table III show the different non-malignant and haematological diseases but also for various systemic illnesses. The aim of this study is to determine the indications, the from July 2012 to December 2017. A total of 152 cases malignant conditions. spectrum of haemotological and non haematological disorders diagnosed by using this procedure. were included in this study. Clinical parameters were Materials & Methods: It was a prospective study comprising 152 patients who underwent bone marrow examination for assessed, peripheral blood smear along with necessary Table III: Bone marrow examination findings. evaluation of haematological and nonhaematological disorders in the Department of Haematology, Enam Medical haematological investigations were done. Than Bone Non Malignant condition College Hospital during the period of 2012 to 2017. Results: In our study male to female ratio was 1.6:1 and common marrow aspiration was done thereafter. When aspirated age group was >45years (n-65, 42.76%). Most common indications for bone marrow examination were pancytopenia material was inadequate or dry tap, trephine biopsy was Megaloblas tic anaemia 4 2.63% (26.97%, n-41) and diagnosis of leukaemia/myeloproliferative neoplasm (25.66%, n-38). 90.13% (n-137) marrows were done. Data was collected and subsequently analyzed. Erythryoid hyperplasia 9 5.92% pathological. Non-malignant conditions were 40.79% (n-62) and malignant conditions were 49.43% (n-75). Non malignant haematological condition were 33.55% (n-51), malignant haematological conditions were 47.37% (n-72). Results Aplastic anaemia 23 15.13% Most common nonmalignant haematological conditions were aplastic anaemia (15.13%, n-23) and immune In this study a total of 152 bone marrow aspirates (BMA) Immune thrombocytopenia purpura 15 9.87% thrombocytopenic purpura (9.87%, n-15). Visceral leishmaniasis was found 3.29% (n-5). Acute myelogenous leukaemia and/or biopsy were done. The age range of the study Myeloid hyperplasia 4 2.63% (14.47%, n-22) and multiple myloma (11.18%, n-17) were the most common malignant haematological condition. subjects were 2 years to 80 years and the mean age of the Secondary deposit was found 1.97% (n-3). Conclusion: Bone marrow examination is a simple invasive procedure for patients was 40.66 years. Most common age group Myelodysplastic syndrome 5 3.29% diagnosis of both haematological and nonhaematological diseases when routine investigations failed to reach the final undergoing BMA was >45 years (Table I). Hypersplenism 2 1.32% diagnosis. Table I: Age distribution of the patients. Normal reactive marrow 15 9.87% Keywords: Bone marrow examination, Haematological disease, Nonhaematological disease. No. of Visceral leish maniasis 5 3.29% Age group Percentage (%) Number of Tables: 03; Number of References: 21; Number of Correspondesces: 03 patients Total 82 53.95% < 15 years 16 10.53% 15- 30 years 43 28.29% Malignant condition 31- 45 years 28 18.42% Acute lymphoblastic leukaemia (ALL) 12 7.89% >45 years 65 42.76% Acute myelogenous leukaemia (AML) 22 14.47% Among them 61.84% (n-94) were male, 38.16% (n-58) Chronic lymphocytic leukaemia (CLL) 1 0.66% were female and male to female ratio was 1.6:1. Most Chronic myelogenous leukaemia (CML) 9 5.92% common indications for BMA cytology examination were Multiple myeloma/plasmacytosis 17 11.18% pancytopenia (26.97%, n-41) and diagnosis of leukaemia/myeloproliferative neoplasm(mpn) (25.66%, Myelofibrosis 1 0.66% n-38). Other indications are summarized in table II. Essential thrombocythemia 3 1.97% Table II: Indications for bone marrow examination. Polycythaemia rubra vera 2 1.32% Number Clinical condition (%) Bone marrow secondary’s 3 1.97% Anaemia 14 9.21% Total 70 46.05% Fever of unknown origin 17 11.18% Pancytopenia 41 26.97% Discussion Bicytopaenia 9 5.92% Bone marrow examination is an important and simple test Thrombocytopaenia 11 7.24% for diagnosis of both haematological and Bodyache,Backache with 19 12.50% nonhaematological diseases in all age group of patients. high ESR The age range of our study subjects were 2 years to 80 Leuco-erythroblastic blood 2 1.32% years and the mean ages of the patients were 40.66 years. picture. Mean age found by in Gandapur ASK et al5, Pudasaini S Diagnosis & management of 39 25.66% et al6, Atla Bl et al7, Kibria SG et al8, Mahfuz H, et al.9 Leukaemia and mpn were 40, 37.9, 32.4, 27.05, 28.2 years in their respective 90.13% (n-137) marrows were pathological and 9.87% studies. The most common age group undergoing BMA (n-15) were normal. Non-malignant conditions were was >45years (42.76%) and lowest age group < 15 years 40.79% (n-62) and malignant conditions were 49.43% (10.53%) in this study. In studies done by Pudasaini S et 6, 16 2019 Volume 31 Number 01 Diagnostic Role of Bone Marrow Examination Chowdhury, et al. Kibria SG et al8, Mahfuz H, et al.9 the majority of the Ahmed SQ et al.11 (11%) and Khodke K et al.17 (6.5%).
Load more

Recommended publications
  • Section 8: Hematology CHAPTER 47: ANEMIA
    Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited.
    [Show full text]
  • An Audit- Indications and Diagnosis of Bone Marrow Biopsies at a Tertiary Care Hospital in Saudi Arabia
    Hematology & Transfusion International Journal Research Article Open Access An audit- indications and diagnosis of bone marrow biopsies at a tertiary care hospital in Saudi Arabia Abstract Volume 6 Issue 5 - 2018 Objective: We conducted the study to observe the common indications of bone marrow Fatma Said Al Qahtani, Naveen Naz Syed biopsy and frequencies of various disorders diagnosed on bone marrow examination Department of Pathology, King Khalid University Hospital, in our center. Kingdom of Saudi Arabia Materials and methods: It was a descriptive retrospective audit conducted at the Fatma Said Al Qahtani, MBBS, KSUFpath, Division of Hematology, Department of Pathology at King Khalid University Hospital Correspondence: Assistant Professor and Consultant Hematopathologist, Division in Riyadh. All bone marrow biopsies performed and reported from January 2014 till of Hematology, Department of Pathology, College of Medicine, December 2015 on patients of all age groups and both genders were analyzed. King Saud University, King Khalid University Hospital, Riyadh, Results: Total 481 bone marrows were examined during this two years’ time period. Kingdom of Saudi Arabia, Tel: 00966-568074991, All relevant information were extracted and analyzed including reasons of referral and Email [email protected] provisional diagnosis made by clinicians. Ages ranged from 5 weeks to 99 years old, Received: August 26, 2018 | Published: October 17, 2018 and male to female ratio 1.4:1. The common indication of bone marrow biopsy is for diagnosis and management of acute leukemia, then for staging of lymphoma and work up of pancytopenia. Acute leukemia followed by myeloproliferative diseases was most frequently diagnosed malignant disorders and idiopathic thrombocytopenic purpura was common benign hematological finding on bone marrow examination.
    [Show full text]
  • Multiple Myeloma
    Multiple myeloma What is multiple myeloma? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines www.anticancerfund.org www.esmo.org MULTIPLE MYELOMA: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of multiple myeloma and appreciate the best treatment choices available according to the subtype of disease. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease. The medical information described in this document is based on the clinical practice guidelines of the European Society for Medical Oncology (ESMO) for the management of multiple myeloma. This guide for patients has been produced in collaboration with ESMO and is disseminated with the permission of ESMO. It has been written by a medical doctor and reviewed by two oncologists from ESMO including the leading author of the clinical practice guidelines for professionals. It has also been reviewed by representatives from the European Oncology Nursing Society (EONS) and the patient representative from ESMO’s Patient Advocates Working Group. More information about the Anticancer Fund: www.anticancerfund.org More information about the European Society for Medical Oncology: www.esmo.org For words marked with an asterisk, a definition is provided at the end of the document. Multiple myeloma: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2017.1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO.
    [Show full text]
  • Bone Marrow Pathology
    Bone marrow pathology Educational course, Belgian Society of Hematology 18 Nov 2017 Dr. J. Somja, CHU Sart Tilman, Liège, [email protected] Learning objectives When ? Bone Why ? marrow What ? examination How ? I. When ? Indications for BM examination Indications for BM examination • Haematological abnormalities that cannot be explained by available clinical and laboratory data. • A good indication is essential for an accurate diagnosis • 3 main indications : – Diagnostic purposes – Staging for malignant diseases – Monitoring Riley et al., JCLA, 2004 II. What? What specimens to collect ? (Bone marrow Particle clot) BONE MARROW Bone marrow aspirate Bacteriology Bone marrow trephine biopsy if necessary Smear Preparation + Heparin +EDTA Heparin FFPE 2-10 days Molecular Morpho, IHC, Flow biology Cytogenetics FISH, (clonal cytometr (clonal days-weeks expansion, NGS) y expansion, Karyotyping (hours) NGS, …) BM biopsy MGG Cyto- FISH Days-Weeks FISH cytology chemistr If necessary touch imprint (hours) y (hours) (days) (hours) Usefull if dry tap BM aspirate or trephine biopsy ? BM ASPIRATE BM BIOPSY • Quick results • Complete assessement of • Fine cytological detail cellularity and architecture • Enumeration of marrow • More sensitive for focal cellular elements lesions • Wider cytochemical stains • Allows grading of fibrosis can be used • Use of IHC • Ideal for flow cytometry, • Useful for assessment of cytogenetics/molecular AA, metastasis, some studies infections BM aspirate or trephine biopsy ? A thorough bone marrow examination includes both BM aspiration and trephine biopsy. – MDS: BM aspirate >>> BM biopsy – MPN: BM aspirate = BM biopsy – MPN/MDS BM aspirate > BM biopsy – AML: BM aspirate >>> BM biopsy – NHL: BM aspirate << BM biopsy – HL: BM aspirate <<< BM biopsy – MM: BM aspirate < BM biopsy – Carcinoma: BM aspirate << BM biopsy III.
    [Show full text]
  • Bone Marrow Cytology Or Bone Marrow Histology 82131 Gauting, Germany
    Indications for bone marrow examination and Heinz Diem, MD Würmtal-Labor Robert-Koch-Allee 7, decision criteria for bone marrow cytology or bone marrow histology 82131 Gauting, Germany In adults all cells of the peripheral blood are generated in the bone marrow The following table contains the indications for bone marrow cytology Armin Funk, MD (haematopoiesis). They all derive from stem cells that are dividing and either and histology. Gemeinschaftspraxis-Pathologie Lachnerstr. 2, remain stem cells (autoreplication) or become precursors of the different 80639 München, Germany cell lineages. The generation of three main cell lineages are distinguished as + examination is mandatory erythropoiesis, granulopoiesis and thrombopoiesis. For lymphocytes the bone (+) examination is helpful, but not mandatory Torsten Haferlach, MD marrow is also an important compartment. In adults haematopoiesis takes ø examination is usually not indicated Munich Leukemia Laboratory place far from the blood vessels (sinus). With increasing maturity the cells get Max-Lebsche-Platz 31, 81377 München, Germany closer to the sinus. The sinus wall represents a barrier. Normally, only mature cells can enter the peripheral blood (blood-bone marrow barrier). Changes in the Bone marrow Bone marrow Rolf Hinzmann, MD, PhD peripheral blood or cytology histology Sysmex Europe GmbH A bone marrow examination is performed in certain clinical conditions suspected diagnosis (Aspiration) (Biopsy) Bornbarch 1, (e.g. lymphoma) or when findings in the peripheral blood (such as anaemia, 22848 Norderstedt, Germany leukocytosis) are otherwise inexplicable. Otherwise inexplicable + (+) In general there are two different types of bone marrow examination: isolated neutropenia Bone marrow cytology, which requires a bone marrow aspiration, and bone marrow histology, which requires a biopsy.
    [Show full text]
  • BONE MARROW SPECIMEN (ASPIRATE and TREPHINE BIOPSY) STRUCTURED REPORTING PROTOCOL (1St Edition 2014)
    BONE MARROW SPECIMEN (ASPIRATE AND TREPHINE BIOPSY) STRUCTURED REPORTING PROTOCOL (1st Edition 2014) Core Document versions: • World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition, 2008 1 ISBN: 978-1-74187-964-3 Publications number (SHPN): (CI) 140018 Online copyright © RCPA 2014 This work (Protocol) is copyright. You may download, display, print and reproduce the Protocol for your personal, non-commercial use or use within your organisation subject to the following terms and conditions: 1. The Protocol may not be copied, reproduced, communicated or displayed, in whole or in part, for profit or commercial gain. 2. Any copy, reproduction or communication must include this RCPA copyright notice in full. 3. With the exception of Chapter 6 - the checklist, no changes may be made to the wording of the Protocol including any Standards, Guidelines, commentary, tables or diagrams. Excerpts from the Protocol may be used in support of the checklist. References and acknowledgments must be maintained in any reproduction or copy in full or part of the Protocol. 4. In regard to Chapter 6 of the Protocol - the checklist: o The wording of the Standards may not be altered in any way and must be included as part of the checklist. o Guidelines are optional and those which are deemed not applicable may be removed. o Numbering of Standards and Guidelines must be retained in the checklist, but can be reduced in size, moved to the end of the checklist item or greyed out or other means to minimise the visual impact. o Additional items for local use may be added but must not be numbered as a Standard or Guideline, in order to avoid confusion with the RCPA checklist items.
    [Show full text]
  • Bone Marrow Test
    Bone Marrow Test Bone marrow biopsy and bone marrow aspiration are procedures performed to diagnose and monitor blood and marrow diseases, often to find out if cancer or infection has spread to the bone marrow. A bone marrow biopsy removes a small amount of bone, fluid, and cells from inside the bone (bone marrow), while a bone marrow aspiration removes only the marrow. What are Bone Marrow Biopsy and Bone Marrow Aspiration? Bone marrow biopsy and bone marrow aspiration are procedures performed to diagnose and monitor blood and marrow diseases, often to find out if cancer or infection has spread to the bone marrow. A bone marrow biopsy removes a small amount of bone, fluid, and cells from inside the bone (bone marrow), while a bone marrow aspiration removes only the marrow. Bone marrow biopsy and aspiration refer to the diagnostic procedures performed to collect a sample of the bone marrow. The bone marrow is a soft, spongy tissue present in some larger bones of the body. Bone marrow biopsy and aspiration are recommended for the detection of the abnormalities related to the bone marrow. This test can help to assess whether the bone marrow is healthy and produces the normal amount of different blood cells. These tests are also advised for monitoring blood and bone marrow diseases such as cancers and a fever of unknown origin. The bone marrow consists of two different portions of which one is fluid in consistency and the other is solid. During bone marrow biopsy, the doctor inserts a needle into the bone to withdraw a small sample of the solid portion.
    [Show full text]
  • Significance of Bone Marrow Histology in the Diagnosis of Acute Myeloid Leukemia
    Significance of Bone Marrow Histology in the Diagnosis of Acute Myeloid Leukemia Usman Younus,1 Kanwal Saba,2 Javeria Aijaz,3 Mulazim Hussain Bukhari,4 Samina Naeem5 Abstract cific esterase, Chloracetate Esterase and Acid Phos- phatase, and SBB. Bone marrow biopsy specimens Background: Acute Myeloid Leukemia (AML) is a were obtained from post superior iliac crest with a heterogeneous disease. The precise diagnosis requires manual trephine and were processed in plastic after a careful morphological examination of a well pre- decalcification. pared bone marrow aspirate along with flow cytometry Results: In all the cases there were better diagnostic and genetic analysis wherever required. Traditionally, clues through histological examination of bone mar- bone marrow biopsy has not been considered an essen- row particularly in assessing the cellularity, degree of tial diagnostic modality for AML. The aim of this stu- fibrosis, extent of blast infiltration, percentage of infla- dy was to assess the diagnostic as well as prognostic mmatory cells, dysplastic changes and residual haema- significance of bone marrow histology in patient with topoiesis. All these features were better noted in histo- acute myeloid leukemia. logical examination of core biopsy. Materials and Methods: Forty (40) patients of AML Conclusion: The histological examination provided underwent a bone marrow examination including an information additional to that provided by aspirate aspirate and a trephine biopsy. Air dried films of peri- smears about the bone marrow changes in AML and pheral blood and aspirates were fixed in methanol and suggested that some of the features may also have pro- stained with Giemsa. The following cytochemical stai- gnostic significance in addition to diagnostic impor- ns were also applied: PAS, Myeloperoxidase, Non spe- tance.
    [Show full text]
  • Bone Marrow Biopsy Evaluation in Cases of Pancytopenia-An
    isord D ers OPEN ACCESS Freely available online od & lo T r B f a n o s l f a u Journal of n s r i o u n o J ISSN: 2155-9864 Blood Disorders & Transfusion Research Article Bone Marrow Biopsy Evaluation in Cases of Pancytopenia-An Institutional Experience Pranati Mohanty1*, Ratiranjan Swain1, Sandhya Rani Sahoo1, Sudha Sethy2 1Department of Pathology, SCB Medical College, Cuttack, Odisha, India; 2Department of Clinical Hematology, SCB Medical College, Cuttack, Odisha, India ABSTRACT Background: Pancytopenia is not a disease entity, but a triad of findings, resulting from various disease processes. It is characterized by anaemia, leucopenia and thrombocytopenia in the peripheral blood. Bone marrow examination is of utmost importance in evaluation of pancytopenia and thereby identification of disease process is helpful for appropriate management. Aims and Objectives: To analyse wide spectrum of haematological diseases giving rise to pancytopenia in bone marrow trephine biopsy. Materials and Methods: This was a prospective study conducted in the department of Pathology and Clinical Hematology, S.C.B. Medical College, Cuttack for a period of 2 years including 122 pancytopenia patients. Complete blood count including peripheral smear examination, followed by bone marrow aspiration (BMA) and trephine biopsy were carried out in all cases. Informations were compiled and analysed. Results: Among 122 patients studied, 63.1% were males and 36.9% females. Aplastic anaemia was the commonest cause of pancytopenia (51%) followed by megaloblastic anaemia (23%). Other causes include acute leukaemia 9%, MDS 6%, primary myelofibrosis 2%, lymphomatous infiltration in the marrow 2%, and multiple myeloma 3%. Metastatic deposit, tuberculosis, haemophagocytic syndrome and hypersplenism constituted 1% each.
    [Show full text]
  • Bone Marrow Morphology in Multiple Myeloma
    BONE MARROW MORPHOLOGY IN MULTIPLE MYELOMA DISSERTATION SUBMITTED FOR M.D.IN PATHOLOGY THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY DEPARTMENT OF PATHOLOGY PSG INSTITUTE OF MEDICAL SCIENCE AND RESEARCH PEELAMEDU, COIMBATORE – 641 004 TAMILNADU, INDIA. APRIL 2012 Certificate CERTIFICATE This is to certify that the dissertation work entitled “ BONE MARROW MORPHOLOGY IN MULTIPLE MYELOMA” submitted by Dr. Yegumuthu. K is the work done by her during the period of study in the department of Pathology, PSGIMS & R from June 2009 to April 2012. This work was done under the guidance of Dr. Alamelu Jayaraman, Professor and Head, Department of Pathology, PSGIMS & R. Dr. Alamelu Jayaraman, Dr.S. Ramalingam, Professor & Head of the Department, Principal, Department of Pathology, PSGIMS & R, PSGIMS & R, Coimbatore-641 004 Coimbatore-641 004 Acknowledgment ACKNOWLEDGEMENT I wish to express my sincere gratitude to Dr.Alamelu Jayaraman , Professor & Head , Department of Pathology , PSG IMSR, for her invaluable guidance and constant support. I would also like to extend my humble thanks to all my Professors, Associate Professors and Assistant professors for their valuable suggestions and encouragement. I am extremely grateful to my husband Dr.M.Subbiah and family members who have been a source of strength in my research pursuit. My thanks and appreciations to all my colleagues who have helped me out with their abilities. I am very thankful to our senior technicians Mrs.Angeline Mary, Mr.Mani and other staff for their skillful technical assistance. I am obliged to all patients who contributed to my study and findings. Lastly I offer my regards to all those who supported me in any respect during the completion of the project.
    [Show full text]
  • Patient Information Sheet Specialist - Bone Marrow Examination
    Patient Information Sheet Specialist - Bone Marrow Examination An appointment is necessary for this test Your doctor has referred you to have a bone marrow “aspiration” or “trephine” performed by a specialist pathologist at Capital Pathology. Description Your bone marrow is responsible for the production of blood cells. These cells include red cells, white cells and platelets. It is also involved in the production of lymphocytes. In adults, active bone marrow is present in a number of sites, the most easily accessible of which is the pelvic bone in your lower back. Procedure Your bone marrow collection involves two procedures, which are both performed at the same site. You are positioned on your side and local anaesthetic is infiltrated into the area from which the biopsy will be taken. When the anaesthetic has taken effect, a small needle is introduced into the bone and some liquid marrow is withdrawn. The second procedure takes a little longer and involves biopsy of the bone itself through a second needle. You will experience a feeling of pressure in the area, and there may be some pain and discomfort associated with the procedure. When the procedure is completed, a dressing is applied and we will ask you to remain resting for five or ten minutes. We suggest that you be accompanied home by a friend or relative if possible Complications are rare. Local bruising occurs occasionally. Other reported complications include local haemorrhage and infection. After the procedure you may experience some discomfort as the local anaesthetic wears off. This can be adequately treated at home with one or two paracetamol (e.g.
    [Show full text]
  • ICSH Guidelines for the Standardization of Bone Marrow Specimens and Reports
    REVIEW ARTICLE INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY ICSH guidelines for the standardization of bone marrow specimens and reports † ‡ § – S.-H. LEE*, W. N. ERBER ,A.PORWIT,M.TOMONAGA,L.C.PETERSON FOR THE INTERNATIONAL COUNCIL FOR STANDARDIZATION IN HEMATOLOGY *Department of Haematology, SUMMARY St George Hospital, Sydney, NSW, Australia The bone marrow examination is an essential investigation for the † Department of Haematology, diagnosis and management of many disorders of the blood and bone Addenbrooke’s Hospital, Cambridge, UK marrow. The aspirate and trephine biopsy specimens are complemen- ‡Department of Pathology, tary and when both are obtained, they provide a comprehensive Radiumhemmet, Karolinska evaluation of the bone marrow. The final interpretation requires the University Hospital, Stockholm, integration of peripheral blood, bone marrow aspirate and trephine Sweden §Department of Hematology, biopsy findings, together with the results of supplementary tests such Nagasaki University Hospital, as immunophenotyping, cytogenetic analysis and molecular genetic Nagasaki City, Japan studies as appropriate, in the context of clinical and other diagnostic – Department of Pathology, findings. Methods for the preparation, processing and reporting of bone Feinberg Medical School of Northwestern University, Chicago, marrow aspirates and trephine biopsy specimens can vary considerably. IL, USA These differences may result in inconsistencies in disease diagnosis or classification that may affect treatment and clinical outcomes. In Correspondence: Szu-Hee Lee, Department of Hae- recognition of the need for standardization in this area, an interna- matology, St George Hospital, Kog- tional Working Party for the Standardization of Bone Marrow arah, Sydney NSW 2217, Australia. Specimens and Reports was formed by the International Council for Tel.: +61 2 91133426; Standardization in Hematology (ICSH) to prepare a set of guidelines Fax: +61 2 91133942; E-mail: szu-hee.lee@sesiahs.
    [Show full text]